Cardiopulmonary Bypass Equipment Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast, 2015-2033

Cardiopulmonary Bypass Equipment Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast, 2015-2033

Summary

Cardiopulmonary Bypass Equipment (Cardiovascular Devices) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Cardiopulmonary Bypass Equipment market for the year 2020 and beyond. Cardiopulmonary bypass is a form of extracorporeal circulation. CPB equipment, also known as heart-lung machine, takes over the function of heart and lungs during an open heart surgery. The CPB equipment has a pump to function as the heart and a membrane oxygenator to function as the lungs. The functions of the heart and lungs which includes circulation of blood, oxygenation, and ventilation are temporarily taken over by the CPB machine.

CPB is routinely used for various cardiac and non-cardiac surgical operations. Cardiopulmonary bypass machines are used during open-heart surgery. The machine helps to bypass the heart so that surgeons can work after the heart is emptied during the surgery. Once the surgery is done and heart starts pumping normally, the heart lung machine is disconnected. The heart-lung machine can take over the work of the heart and lungs for several hours.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Cardiopulmonary Bypass Equipment and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Cardiopulmonary Bypass Equipment market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Cardiopulmonary Bypass Equipment market.
• Competitive dynamics insights and trends provided for Cardiopulmonary Bypass Equipment market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: LivaNova PLC, Medtronic Plc, Terumo Corp, Getinge AB, Braile Biomedica Ltda, Senko Medical Instrument Manufacturing Co Ltd, Technowood Corp, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Cardiopulmonary Bypass Equipment marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The Model will enable you to -

• Understand the impact of COVID-19 on Cardiopulmonary Bypass Equipment market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Cardiopulmonary Bypass Equipment market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Cardiopulmonary Bypass Equipment market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Cardiopulmonary Bypass Equipment market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Please note: this is delivered as an Excel file.